Skip to main content
All lobbying filings

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Lobbying for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $159,409.00 income · posted Apr 14, 2026

Official filing document

 Bills named in this filing 14
  • S 2292
    Over-the-Counter Monograph Drug User Fee Amendments
  • HR 4273
    Over-the-Counter Monograph Drug User Fee Amendments
  • S 355
    FDA Modernization Act 3.0
  • HR 2821
    FDA Modernization Act 3.0
  • HR 3686
    SAFE Sunscreen Standards Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
  • S 2491
    SAFE Sunscreen Standards Act
  • S 2529
    A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription …
  • HR 6868
    ACCESS Through OTC Innovation Act
  • S 3122
    Better FDA Act of 2025
  • HR 7366
    Dietary Supplement Regulatory Uniformity Act
  • HR 4958
    GRAS Act
  • HR 1219
    Oral Health Products Inclusion Act
 Lobbying activity 5
Health Issues

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.

Pharmacy

H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling

Consumer Issues/Safety/Products

- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.

Taxation/Internal Revenue Code

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

Manufacturing

- Pharmaceutical Tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem